Journal rankings · indicator year 2015
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2015
Oncology journal rankings 2015
188 ranked journals · Subfield in Medicine
Oncology has 188 ranked journals in 2015. The median journal has an OJR of 0.97, below the world average of 1.00, unchanged on 2014; Q1 starts at OJR 1.58. The top three are CA A Cancer Journal for Clinicians, The Lancet Oncology, and Cancer Cell.
Ranks and citation indicators: 2015. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2012–2014, the window the 2015 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
Show all 42 subfields
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
188 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2014. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2012–2014, the window the 2015 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2012–2014 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2006 to 2015. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 52.59Q1 | 139.43 4.35 up from 2014 | 76 | 100% | $4,330 | ||
2The Lancet OncologyElsevier BV · United Kingdom | 6.96Q1 | 16.72 1.35 up from 2014 | 1,021 | 19% | $7,280 | ||
3Cancer CellCell Press · Netherlands | 6.78Q1 | 17.43 1.20 down from 2014 | 538 | 100% | $10,400 | ||
4Nature MedicineNature Portfolio · United States | 6.10Q1 | 15.17 1.48 up from 2014 | 1,280 | 52% | $12,690 | ||
5Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 5.84Q1 | 13.76 0.13 up from 2014 | 2,481 | 7% | — | ||
6Seminars in Cancer BiologyElsevier BV · United States | 3.85Q1 | 9.76 1.32 down from 2014 | 195 | 47% | $6,060 | ||
7Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.46Q1 | 9.14 0.32 down from 2014 | 2,195 | 40% | — | ||
8Annals of OncologyElsevier BV · Netherlands | 3.35Q1 | 8.93 1.29 up from 2014 | 1,565 | 100% | $5,080 | ||
9JNCI Journal of the National Cancer InstituteOxford University Press · United States | 3.14Q1 | 7.53 0.27 down from 2014 | 880 | 65% | $5,436 | ||
10Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 2.93Q1 | 8.05 2.76 up from 2014 | 208 | 32% | — | ||
11Clinical Pharmacology & TherapeuticsWiley · United States | 2.86Q1 | 5.54 1.03 down from 2014 | 722 | 32% | $4,410 | ||
12Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.66Q1 | 9.91 0.81 up from 2014 | 295 | 24% | $4,910 | ||
13CancerWiley · United States | 2.63Q1 | 5.95 0.52 up from 2014 | 1,650 | 82% | $4,790 | ||
14Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 2.57Q1 | 5.65 0.21 down from 2014 | 398 | 74% | — | ||
15British Journal of CancerSpringer Nature · United Kingdom | 2.38Q1 | 6.46 0.64 up from 2014 | 1,987 | 100% | $5,190 | ||
16European Journal of EpidemiologySpringer Science+Business Media · Italy | 2.35Q1 | 6.81 1.79 up from 2014 | 316 | 54% | $3,690 | ||
17OncologyKarger Publishers · Switzerland | 2.35Q1 | 7.66 2.64 up from 2014 | 355 | 21% | — | ||
18JNCI MonographsOxford University Press · United Kingdom | 2.31Q1 | 4.07 1.32 up from 2014 | 106 | 81% | — | ||
19International Journal of CancerWiley · United States | 2.26Q1 | 5.98 0.61 up from 2014 | 1,945 | 83% | $5,030 | ||
20Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.25Q1 | 5.83 0.22 down from 2014 | 839 | 13% | — | ||
21Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.14Q1 | 5.34 0.18 up from 2014 | 1,145 | 25% | — | ||
22Journal of Hematology & OncologyOABioMed Central · United Kingdom | 2.11Q1 | 7.27 0.82 up from 2014 | 269 | 100% | $4,990 | ||
23The Cancer JournalLippincott Williams & Wilkins · United States | 2.09Q1 | 4.51 0.98 down from 2014 | 227 | 35% | — | ||
24Seminars in OncologyElsevier BV · United States | 2.05Q1 | 4.81no change | 262 | 25% | $3,550 | ||
25Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 2.00Q1 | 4.89 1.00 up from 2014 | 61 | 100% | $2,800 | ||
26Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.99Q1 | 4.19 1.00 down from 2014 | 300 | 18% | — | ||
27Frontiers in OncologyOAFrontiers Media · Switzerland | 1.96Q1 | 5.35 0.69 up from 2014 | 919 | 100% | $3,801 | ||
28The OncologistOAAlphaMed Press · United Kingdom | 1.89Q1 | 4.91 0.08 down from 2014 | 614 | 96% | $3,852 | ||
29Breast Cancer ResearchOABioMed Central · United Kingdom | 1.86Q1 | 5.20 0.32 up from 2014 | 672 | 100% | $4,190 | ||
30CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.85Q1 | 5.65 2.43 up from 2014 | 276 | 100% | $3,499 | ||
31Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.84Q1 | 3.96 0.40 down from 2014 | 674 | 7% | — | ||
32Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.83Q1 | 4.00 1.09 down from 2014 | 87 | 56% | $4,090 | ||
33Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.83Q1 | 6.04 1.00 up from 2014 | 329 | 14% | $4,190 | ||
34Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 1.82Q1 | 5.52 2.48 up from 2014 | 79 | 100% | $2,800 | ||
35Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.82Q1 | 5.85 1.09 up from 2014 | 126 | 39% | — | ||
36Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.81Q1 | 5.61 0.39 up from 2014 | 432 | 100% | $4,590 | ||
37Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 1.79Q1 | 4.63 0.23 up from 2014 | 446 | 37% | — | ||
38Journal of Cancer EpidemiologyHindawi Publishing Corporation · United Kingdom | 1.79Q1 | 7.00 2.69 up from 2014 | 62 | 100% | $950 | ||
39World Journal of Clinical OncologyOABaishideng Publishing Group · United States | 1.79Q1 | 4.63 3.29 up from 2014 | 148 | 98% | — | ||
40Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.76Q1 | 4.36 0.47 down from 2014 | 982 | 37% | — | ||
41Cancer Management and ResearchOADove Medical Press · New Zealand | 1.73Q1 | 4.83 0.51 up from 2014 | 133 | 100% | $2,836 | ||
42Cancer ControlOASAGE Publishing · United States | 1.73Q1 | 3.92 1.19 down from 2014 | 110 | 64% | $2,650 | ||
43Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.70Q1 | 3.45 0.55 down from 2014 | 676 | 25% | — | ||
44Cancer Research and TreatmentOAKorean Cancer Association · South Korea | 1.69Q1 | 3.95 1.55 down from 2014 | 194 | 100% | — | ||
45Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.69Q1 | 3.75 0.43 down from 2014 | 457 | 21% | — | ||
46BMC CancerOABioMed Central · United Kingdom | 1.58Q1 | 4.22 0.32 down from 2014 | 2,238 | 100% | $3,390 | ||
47Chemotherapy Research and PracticeHindawi Publishing Corporation · Egypt | 1.58Q1 | 2.06 2.17 down from 2014 | 39 | 100% | — | ||
48Breast CareKarger Publishers · Switzerland | 1.55Q2 | 5.27 3.19 up from 2014 | 278 | 90% | — | ||
49World Journal of Gastrointestinal OncologyOAUnited States | 1.55Q2 | 3.98 0.39 up from 2014 | 124 | 100% | — | ||
50Current Oncology ReportsSpringer Science+Business Media · United States | 1.55Q2 | 3.34 0.23 down from 2014 | 202 | 13% | $5,090 |
Subfields of Medicine, with Oncology highlighted.
- Surgery773
- Pulmonary and Respiratory Medicine297
- Public Health, Environmental and Occupational Health252
- Cardiology and Cardiovascular Medicine238
- Oncology188
- Infectious Diseases182
- Epidemiology176
- Neurology151
- Endocrinology, Diabetes and Metabolism141
- Radiology, Nuclear Medicine and Imaging138
- Physiology129
- Psychiatry and Mental health123
- Orthopedics and Sports Medicine95
- Pediatrics, Perinatology and Child Health85
- Dermatology74
- Ophthalmology74
- Hematology71
- Obstetrics and Gynecology61
- Rheumatology58
- Nephrology49
- Reproductive Medicine45
- Complementary and alternative medicine42
- Pharmacology42
- Emergency Medicine36
- Geriatrics and Gerontology36
- Otorhinolaryngology34
- Rehabilitation29
- Pathology and Forensic Medicine23
- Critical Care and Intensive Care Medicine22
- Genetics19
- Hepatology19
- Immunology and Allergy17
- Anesthesiology and Pain Medicine12
- Urology11
- Gastroenterology6
- Internal Medicine5
- Family Practice3
- Transplantation3
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2015. Corpus-wide, 78.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
67 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2012–2014, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2015. Publication window: 2012–2014. How these summaries are calculated
- Ranked journals
- 188
- Window papers (baseline)
- 98,660 +14.5% from indicator year 2012
- Median OJR
- 0.967 -3.9% from indicator year 2012
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2012–2014 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.